Ovarian Cancer Research Fund
| Motto | Together, we can change the future. |
|---|---|
| Founded | 1994 |
| Founder | Sol Schreiber |
| Type | Nonprofit Organization / NGO |
| Focus | Ovarian cancer research |
| Location |
|
| Services | Charitable services |
|
Key people
|
Audra Moran, CEO John W. Hansbury, Esq., Co-President Sherry Jacobson, Co-President Sol Schreiber, Esq., Founder and Chair Carmel J. Cohen, M.D., Scientific Chair Edward Labaton, Esq., Secretary Jacqueline Bianco, Treasurer Brooke Goodman Cohen, Director Mindy Gray, Director Donna Nadler, Director |
| Mission | To fund scientific research that leads to more effective identification, treatment, and ultimately a cure for ovarian cancer, as well as related educational and support initiatives. |
| Website | http://www.ocrf.org |
|
Formerly called
|
Ann Schreiber Ovarian Cancer Research Fund |
Ovarian Cancer Research Fund (OCRF) was founded in December, 1994, as the Ann Schreiber Ovarian Cancer Research Fund by Sol Schreiber in memory of his wife, Ann, who died of ovarian cancer. The organization later became the Ovarian Cancer Research Fund. In 1997, Liz Tilberis, editor-in-chief of Harpers Bazaar and also battling ovarian cancer, became the organization’s first president. Liz, with help from Donna Karan, started OCRF’s signature fundraiser, Super Saturday, hosting the first one in 1998 in the Hamptons in New York. The first Super Saturday raised $200,000, and today raises over $3.5 million annually.
OCRF is now the oldest and largest charity in the U.S. funding ovarian cancer research. OCRF has awarded over $50 million in research through grants to scientists at 63 medical centers in 29 states and Washington, D.C. OCRF launched a patient program in 2012, called Woman to Woman, for women undergoing treatment for any type of gynecologic cancer. OCRF is governed by a Board of Directors.
The majority of ovarian cancer research funding in the United States comes from two government sources—the National Cancer Institute and United States Department of Defense. OCRF is the largest non-governmental funding source of ovarian cancer research,. OCRF research grants are approved by a committee of gynecologic oncologists and scientists treating and/or studying ovarian cancer.
Through grantmaking programs, OCRF funds scientific research at cancer centers and academic research centers in the U.S. The first grants were awarded in 1998. OCRF offers three grants:
OCRF selects research projects through a peer-review process, conducted once each year by a panel of advisors called the Scientific Advisory Committee (SAC), which is chaired by Jeff Boyd, Ph.D., of Fox Chase Cancer Center.
Less than 10% of applicants are awarded grants. Institutions that have received the most grants include University of Texas MD Anderson Cancer Center, University of Pennsylvania, Fox Chase Cancer Center, Duke University, and Brigham and Women’s Hospital.
...
Wikipedia